Search Results
Search for other papers by K Katoh in
Google Scholar
PubMed
Search for other papers by G Furukawa in
Google Scholar
PubMed
Search for other papers by K Kitade in
Google Scholar
PubMed
Search for other papers by N Katsumata in
Google Scholar
PubMed
Search for other papers by Y Kobayashi in
Google Scholar
PubMed
Search for other papers by Y Obara in
Google Scholar
PubMed
Ultradian growth hormone rhythm in the rat: effects of feeding, hyperglycemia, and insulin-induced hypoglycemia. Endocrinology 99 720 –727. Thomas GB , Mercer JE, Karalis T, Rao A, Cummins JT & Clarke IJ 1990 Effect of
Search for other papers by R Wang in
Google Scholar
PubMed
Search for other papers by N Yashpal in
Google Scholar
PubMed
Search for other papers by F Bacchus in
Google Scholar
PubMed
Search for other papers by J Li in
Google Scholar
PubMed
mice that over-express HGF in islets are resistant to the diabetogenic effects of the β-cell toxin streptozotocin ( Garcia-Ocana et al. 2001 ), and β-cell proliferation, islet cell mass and hypoglycemia are increased. Thus it is speculated that HGF
Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other papers by Neehar Gupta in
Google Scholar
PubMed
Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other papers by Edward Park in
Google Scholar
PubMed
Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other papers by Harmanjit Sandhu in
Google Scholar
PubMed
Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other papers by Tracy Goh in
Google Scholar
PubMed
Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other papers by Vaja Tchipashvili in
Google Scholar
PubMed
Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada
Search for other papers by Adria Giacca in
Google Scholar
PubMed
glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment. Metabolism 49 984 –989.
Search for other papers by Run Yu in
Google Scholar
PubMed
Search for other papers by Martha Cruz-Soto in
Google Scholar
PubMed
Search for other papers by Sergio Li Calzi in
Google Scholar
PubMed
Search for other papers by Hongxiang Hui in
Google Scholar
PubMed
Search for other papers by Shlomo Melmed in
Google Scholar
PubMed
JP, Mizukami Y, Li J, Graeme-Cook F & Chung DC 2005 Overexpression of cyclin D1 in pancreatic β-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54 712 –719. Zou H , McGarry TJ, Bernal T
Search for other papers by Sarah L Armour in
Google Scholar
PubMed
Search for other papers by Jade E Stanley in
Google Scholar
PubMed
Search for other papers by James Cantley in
Google Scholar
PubMed
Division of Diabetes, Endocrinology, & Metabolism, Vanderbilt University Medical Center School of Medicine, Nashville, Tennessee, USA
Search for other papers by E Danielle Dean in
Google Scholar
PubMed
Search for other papers by Jakob G Knudsen in
Google Scholar
PubMed
normal glucose concentrations . Metabolism: Clinical and Experimental 53 1443 – 1448 . ( https://doi.org/10.1016/j.metabol.2004.06.011 ) Bolli GB Gottesman IS Cryer PE & Gerich JE 1984 Glucose counterregulation during prolonged hypoglycemia
Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada
Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
Banting & Best Diabetes Centre, Toronto, Ontario, Canada
Search for other papers by Margaret K Hahn in
Google Scholar
PubMed
Banting & Best Diabetes Centre, Toronto, Ontario, Canada
Department of Physiology, University of Toronto, Toronto, Ontario, Canada
Search for other papers by Adria Giacca in
Google Scholar
PubMed
Department of Physiology, University of Toronto, Toronto, Ontario, Canada
Search for other papers by Sandra Pereira in
Google Scholar
PubMed
reported that shorter fasting (2 h) is ideal when performing ITTs because hepatic glycogen content is similar to the nonfasted state ( Carper et al. 2020 ) and there is less risk of fatal hypoglycemia. Genetic background Genetic background of mice
Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, Iowa, USA
Search for other papers by Andrew W Norris in
Google Scholar
PubMed
Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, Iowa, USA
Search for other papers by Katie Larson Ode in
Google Scholar
PubMed
Search for other papers by Lina Merjaneh in
Google Scholar
PubMed
Diabetes Center, University of California San Francisco, San Francisco, California, USA
Search for other papers by Srinath Sanda in
Google Scholar
PubMed
Search for other papers by Yaling Yi in
Google Scholar
PubMed
Search for other papers by Xingshen Sun in
Google Scholar
PubMed
Department of Anatomy and Cell Biology, University of Iowa, Iowa City, Iowa, USA
Search for other papers by John F Engelhardt in
Google Scholar
PubMed
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA
Search for other papers by Rebecca L Hull in
Google Scholar
PubMed
hyperglycemia and hepatic insulin resistance in type 2 diabetes, while an inappropriately low counter-regulatory glucagon response is an important contributor to hypoglycemia in diabetes. An insufficient glucagon response to arginine has been reported in CF
Search for other papers by Xianxian Huang in
Google Scholar
PubMed
Search for other papers by Jing Liu in
Google Scholar
PubMed
Search for other papers by Guangquan Peng in
Google Scholar
PubMed
Search for other papers by Mingyue Lu in
Google Scholar
PubMed
Search for other papers by Zhongbo Zhou in
Google Scholar
PubMed
Search for other papers by Neng Jiang in
Google Scholar
PubMed
Search for other papers by Zhiming Yan in
Google Scholar
PubMed
glucagon release during hypoglycemia, ultimately regulating glucose levels without impacting insulin secretion ( Christensen et al. 2011 ). However, compared to GLP-1, GIP has exhibited a noticeable decrease in acute insulinotropic activity in individuals
Search for other papers by Niels L Mulder in
Google Scholar
PubMed
Search for other papers by Rick Havinga in
Google Scholar
PubMed
Search for other papers by Joost Kluiver in
Google Scholar
PubMed
Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by Albert K Groen in
Google Scholar
PubMed
Search for other papers by Janine K Kruit in
Google Scholar
PubMed
homeostasis remained unaltered in chow-fed mice overexpressing miR-132 indicating that the risk on hypoglycemia is low. Mice treated with dsAAV-RIP-miR132, however, did show improved insulin secretion during high-fat diet feeding. Recent findings identified
Search for other papers by Tatiana Dorfman in
Google Scholar
PubMed
Search for other papers by Yulia Pollak in
Google Scholar
PubMed
Search for other papers by Rima Sohotnik in
Google Scholar
PubMed
Search for other papers by Arnold G Coran in
Google Scholar
PubMed
Search for other papers by Jacob Bejar in
Google Scholar
PubMed
Laboratory of Intestinal Adaptation and Recovery, Departments of Pediatric Surgery B, Pathology, Section of Pediatric Surgery, The Ruth and Bruce Rappaport Faculty of Medicine, Technion‐Israel Institute of Technology, Haifa, Israel
Search for other papers by Igor Sukhotnik in
Google Scholar
PubMed
.5). Blood glucose levels vary between 400–550 in diabetic rats and 300–350 in diabetic rats treated with insulin. The animals had no Clinical signs of hypoglycemia. Cell proliferation and apoptosis Diabetic rats (group B) demonstrated a significant increase